GlassScriptPhysician profile
Jackie Gilliard
NPI 1134139645
$1,761.42
in general payments reported to CMS, 2019-2025
19 companies · $605 in 2025
The $605 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $121 · 2022: $204 · 2023: $319 · 2024: $198 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $379.21 | 2019-2023 | Dyanavel Xr, Quillivant, Quillichew Er |
| Corium, LLC | $277.72 | 2023-2025 | Azstarys |
| Ars Pharmaceuticals Operations, INC. | $138.70 | 2025 | Neffy |
| Alk-Abello, INC | $130.08 | 2024-2025 | Neffy, Grastek, Odactra |
| Glaxosmithkline, LLC. | $119.08 | 2019 | |
| Merck Sharp & Dohme LLC | $116.82 | 2023-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Pfizer INC. | $114.32 | 2019-2024 | |
| Sobi, INC | $100.90 | 2020-2023 | |
| Cranial Technologies, INC | $86.50 | 2022-2025 | Doc Band |
| Sanofi Pasteur INC. | $62.33 | 2020-2022 | |
| Aytu Biopharma, INC. | $41.18 | 2025 | |
| Neos Therapeutics, LP | $38.42 | 2023-2025 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $34.55 | 2025 | Vpriv |
| Vertical Pharmaceuticals, LLC | $27.79 | 2024 | Relexxii |
| Alexion Pharmaceuticals, INC. | $25.01 | 2025 | Koselugo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $18.48 | 2022 | |
| Hologic Sales and Service, LLC | $17.52 | 2025 | Aptima |
| Collegium Pharmaceutical, INC. | $16.59 | 2025 | Jornay Pm |
| Kaleo, INC. | $16.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackie Gilliard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.